☆ 4.6 Review

Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children

CANADIAN JOURNAL OF CARDIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

BNT162b2 mRNA Vaccination Against COVID-19 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021-April 2022

Laura D. Zambrano et al.

Summary: A multicenter public health investigation conducted in the US found a decreased likelihood of multisystem inflammatory syndrome in children (MIS-C) among vaccinated individuals aged 5-18 years during periods of Delta and Omicron predominance.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Letter Pediatrics

Call for a universal PIMS-TS/MIS-C case definition

Sophie Rhys-Evans

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination

Dongngan T. Truong et al.

Summary: This study retrospectively analyzed the clinical characteristics and short-term outcomes of young individuals with suspected myocarditis after COVID-19 vaccination. The results showed that most cases of suspected myocarditis had a mild clinical course with rapid resolution of symptoms, and abnormal findings on cardiac MRI were frequent.

CIRCULATION (2022)

Add to Collection

Letter Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France

Michael Levy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Keith Sacco et al.

Summary: Transcriptomic, proteomic and immune repertoire profiling revealed distinct peripheral features of MIS-C and pediatric COVID-19, providing valuable insights into the pathophysiology and potential therapeutic strategies for these disorders.

NATURE MEDICINE (2022)

Add to Collection

Article Pediatrics

Cardiac Magnetic Resonance Findings after Multisystem Inflammatory Syndrome in Children

Matthew L. Dove et al.

Summary: This study used cardiac magnetic resonance (MR) imaging to analyze the cardiac findings of children recovered from multisystem inflammatory syndrome in children (MIS-C) for more than three months. The results showed that most patients had a low left ventricular ejection fraction, and some patients developed valvular regurgitation and coronary artery dilation. Cardiac MR performed three to five months after diagnosis did not reveal evidence of acute myocarditis, but two patients were found to have myocardial fibrosis.

JOURNAL OF PEDIATRICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID-19 induced MIS-C

Conor McCafferty et al.

Summary: This study utilized proteomics to analyze plasma proteins in healthy children, children with MIS-C, and children with COVID-19 ARDS, and identified the affected pathways. The results revealed differentially expressed proteins among these groups and identified key pathways associated with MIS-C and COVID-19 ARDS.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease

Pradipta Ghosh et al.

Summary: Multisystem inflammatory syndrome in children (MIS-C) emerged during the COVID-19 pandemic and shares similarities with Kawasaki disease (KD). Both syndromes exhibit similar host immune responses, but differ in other laboratory parameters and cardiac phenotypes.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Pediatrics

Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation

Anna R. Yousaf et al.

Summary: This study investigated reports of individuals aged 12-20 years with MIS-C after COVID-19 vaccination. The findings suggest that MIS-C after COVID-19 vaccination is rare, but continued monitoring and reporting are warranted.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Add to Collection

Article Pediatrics

Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study

Ulrikka Nygaard et al.

Summary: This study investigates the incidence and clinical phenotype of MIS-C in children after infection with the SARS-CoV-2 Delta variant. The authors found that the incidence of MIS-C in unvaccinated children during the Delta wave was similar to that in the first year of the pandemic. They also found high vaccine effectiveness against MIS-C.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Add to Collection

Article Medicine, General & Internal

Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children

Walid Abuhammour et al.

Summary: This prospective, multicenter cohort study assessed the genetic and clinical characteristics of patients with primarily Arab and Asian origin in Middle Eastern patients with multisystem inflammatory syndrome in children (MIS-C). The results showed the presence of rare, likely deleterious genetic variants in MIS-C patients, which may contribute to the development of the disease.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Rheumatology

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study

Jochen Pfeifer et al.

Summary: Autoantibodies against IL-1Ra were observed in a high proportion of patients with MIS-C and may impair IL-1Ra function, leading to increased IL-1 beta signaling in MIS-C.

LANCET RHEUMATOLOGY (2022)

Add to Collection

Article Pediatrics

Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications

Da Eun Roh et al.

Summary: This study investigated the difference between Kawasaki disease (KD) with and without a recent history of SARS-CoV-2 infection. The study found that patients with a history of COVID-19 had a higher median age, higher incidence of cervical lymphadenopathy, and a lower incidence of BCGitis compared to patients without a history of COVID-19. Patients with a history of COVID-19 also had a longer hospital stay, lower platelet count, and higher hemoglobin and ferritin levels. After treatment, patients with a history of COVID-19 had lower platelet count, higher percentage of neutrophils, and higher neutrophil-to-lymphocyte ratio. Although not statistically significant, only patients with a history of COVID-19 required infliximab treatment due to prolonged fever. The incidence of cardiovascular complications did not differ between the groups.

FRONTIERS IN PEDIATRICS (2022)

Add to Collection

Article Medicine, General & Internal

Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States

Jennifer A. Burney et al.

Summary: Public health measures implemented during the COVID-19 pandemic had an impact on the incidence of KD, with a decrease in KD cases during the period of masking and school closure, and no association with different levels of sheltering in place.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Medicine, General & Internal

Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease

Mikayla Beckley et al.

Summary: This study aims to describe the outcomes of patients with Kawasaki disease (KD) to SARS-CoV-2 infection or vaccination. The findings suggest that the mRNA vaccines may be safe and COVID-19 may not be severe for patients with a history of KD.

JAMA NETWORK OPEN (2022)

Add to Collection

Article

Examining the Association Between MIS-C and the Child Opportunity Index at a Single Center

Jordan Tyris et al.

Hospital pediatrics (2022)

Add to Collection

Article Medicine, General & Internal

Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis

Beom Joon Kim et al.

Summary: This study investigated the impact of the COVID-19 pandemic on Kawasaki disease in Korea. The results showed a decrease in hospital admissions for Kawasaki disease since the onset of the pandemic, without significant changes in clinical courses and complications.

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

Add to Collection

Article Rheumatology

Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study

Jackeline J. Rodriguez-Smith et al.

Summary: Our findings demonstrate that MIS-C can be distinguished from Kawasaki disease primarily by elevated CXCL9 concentrations. Stratification of MIS-C patients by high or low CXCL9 concentrations suggests MAS-like pathophysiology in severe MIS-C cases, indicating new possibilities for diagnosis and treatment.

LANCET RHEUMATOLOGY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children

Tarek Alsaied et al.

Summary: Multisystem inflammatory syndrome in children, triggered by SARS-CoV-2 infection, is a severe inflammatory disease with common symptoms of persistent fever and cardiac manifestations. Treatment mainly aims at reversing the inflammatory response with immunomodulatory medications.

CIRCULATION (2021)

Add to Collection

Editorial Material Rheumatology

MIS-C: early lessons from immune profiling

Lauren A. Henderson et al.

Summary: The immune response in MIS-C shows distinct characteristics compared to acute SARS-CoV-2 infection and Kawasaki disease, suggesting potential differences in underlying mechanisms. The immune landscape in MIS-C changes during the course of the disease, but further research is needed to determine the specific mechanisms and relationship with Kawasaki disease.

NATURE REVIEWS RHEUMATOLOGY (2021)

Add to Collection

Review Pediatrics

COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis

Jun Yasuhara et al.

Summary: The study revealed that MIS-C results in multi-organ failure, including gastrointestinal manifestations, myocardial dysfunction, and coronary abnormalities, demonstrating distinct features from Kawasaki disease.

PEDIATRIC PULMONOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health

Megan S. Rafferty et al.

Summary: The emergence of MIS-C in children with potential severe outcomes highlights the importance of understanding its etiology and long-term consequences. While rare, the lack of information necessitates further research and mitigation efforts to address potential predisposing factors and ensure well-informed guidelines for public health.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

Add to Collection

Review Pediatrics

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

Levi Hoste et al.

Summary: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.

EUROPEAN JOURNAL OF PEDIATRICS (2021)

Add to Collection

Review Rheumatology

Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison

Chetan Sharma et al.

Summary: Children and adolescents infected with SARS-CoV-2 often exhibit mild symptoms, but may also develop a pediatric systemic vasculitis called MIS-C. This condition shares features with myocarditis and Kawasaki disease. Research indicates that MIS-C is a result of an exaggerated immune response triggered by prior exposure to SARS-CoV-2.

NATURE REVIEWS RHEUMATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

Leora R. Feldstein et al.

Summary: Comparing the clinical characteristics and outcomes of patients with MIS-C and COVID-19 can help distinguish between the two conditions and improve health outcomes. Patterns of clinical presentation and organ system involvement were identified in this case series, providing valuable information for differentiation of MIS-C and COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction

Caroline Diorio et al.

Summary: Multi-inflammatory syndrome in children (MIS-C) is a major complication of SARS-CoV-2 infection in pediatric patients, characterized by cardiovascular and hyperinflammatory symptoms of varying degrees. Dysregulated IFN gamma responses in MIS-C patients may contribute to clinical heterogeneity.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Pediatrics

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA a retrospective surveillance study

Joseph Y. Abrams et al.

Summary: Factors such as age, race, clinical symptoms, and laboratory markers were found to be associated with severe outcomes in patients with MIS-C. These findings highlight the importance of early recognition and prompt management for patients with MIS-C.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19

Eveline Y. Wu et al.

Summary: MIS-C associated with COVID-19 can lead to cardiac manifestations in up to 80% of children, including myocarditis and coronary artery aneurysms, with current treatments such as inotropic support, immunomodulatory therapy, and anti-coagulation showing effectiveness in resolving these issues.

CURRENT CARDIOLOGY REPORTS (2021)

Add to Collection

Article Immunology

Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children

Anjali Ramaswamy et al.

Summary: Through various analyses, specific biological features were identified in MIS-C patients, including myeloid dysfunction, elevated cytotoxicity gene expression in NK and CD8(+) T cells, and autoimmune characteristics, which could potentially improve the diagnosis and prediction of disease severity in MIS-C.

IMMUNITY (2021)

Add to Collection

Review Immunology

SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

Vanessa Sancho-Shimizu et al.

Summary: MIS-C, a newly emerging syndrome in children associated with COVID-19, shows heterogeneity resembling KD, possibly triggered by viruses and potentially linked to rare inborn errors of immunity altering the immune response. Discovery of monogenic IEIs underlying MIS-C may pave the way for a new genetic approach to classic KD.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Virology

The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis

Yan Zhao et al.

Summary: This study analyzed inflammatory markers in children with multisystem inflammatory syndrome (MIS-C) compared to those with COVID-19, showing significant differences in severity among MIS-C patients. The measurement of inflammatory markers may assist clinicians in accurately evaluating and diagnosing MIS-C and associated disorders.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Pediatrics

Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic

Ermias D. Belay et al.

Summary: This study conducted a cross-sectional analysis of a large cohort of patients with MIS-C in the United States, identifying 2 peaks that followed COVID-19 peaks by 2 to 5 weeks. The geographic and temporal association of MIS-C with the COVID-19 pandemic suggested that MIS-C resulted from delayed immunologic responses to SARS-CoV-2 infection. Clinical manifestations varied by age and presence or absence of preceding COVID-19.

JAMA PEDIATRICS (2021)

Add to Collection

Article Immunology

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome

Francesca Caldarale et al.

Summary: In children with COVID-19, there is an immune response suggestive of type I interferon activation, possibly due to recent interaction with the virus, while in MIS-C, the immune response is characterized by elevation of inflammatory cytokines/chemokines, which may contribute to the multisystem and cardiovascular damage observed in MIS-C.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era A Nationwide Observational Study in Korea

Ji-Man Kang et al.

CIRCULATION (2021)

Add to Collection

Article Allergy

Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C)

Janet Chou et al.

Summary: MIS-C is a pediatric complication of severe acute respiratory syndrome coronavirus 2 infection characterized by multiorgan inflammation and cardiovascular dysfunction. Genetic risk factors such as variants in SOCS1, XIAP, and CYBB have been identified in patients with MIS-C, leading to an inflammatory immune cell transcriptome enriched in specific pathways even after recovery. This suggests a potential role for next-generation sequencing in identifying monogenic susceptibility to inflammation in previously healthy children with MIS-C.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Racial and Ethnic Disparities in Multisystem Inflammatory Syndrome in Children in the United States, March 2020 to February 2021

Bryan Stierman et al.

Summary: There are disparities in MIS-C by race and ethnicity in the United States, even after controlling for COVID-19 disparities and geographic variations. Hispanic children have a higher proportion of MIS-C, along with non-Hispanic Black children. Non-Hispanic White children have a lower proportion of MIS-C.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children

Noam D. Beckmann et al.

Summary: Multisystem inflammatory syndrome in children (MIS-C) presents symptoms similar to Kawasaki disease and affects individuals under 21 years of age. RNA sequencing revealed signatures related to natural killer cell activation and CD8+ T cell exhaustion in the blood of MIS-C patients, showing similarities with Kawasaki disease.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Rheumatology

Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease

Hulya Bukulmez

Summary: This article reviews the differences and similarities between multisystem inflammatory syndrome in children (MIS-C) and other known multisystem inflammatory diseases seen in children, particularly Kawasaki disease. Recent findings indicate that COVID-19 caused by SARS-CoV-2 is relatively mild in children, but a subset may develop MIS-C, which has become a major concern.

CURRENT RHEUMATOLOGY REPORTS (2021)

Add to Collection

Editorial Material Pediatrics

Disparities in Susceptibility to Multisystem Inflammatory Syndrome in Children

Evida A. Dennis-Heyward

JAMA PEDIATRICS (2021)

Add to Collection

Article Immunology

Polyclonal expansion of TCR Vβ 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children

Marion Moreews et al.

Summary: MIS-C is characterized by increased serum inflammatory cytokines and a specific expansion of activated T cells expressing the V.21.3 T cell receptor beta chain variable region, not directed against SARS-CoV-2 antigenic peptides, which differentiates it from KD, TSS, and acute COVID-19. The T cell repertoire returns to baseline soon after MIS-C resolution.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Amanda B. Payne et al.

Summary: In this study, it was found that Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare complication associated with SARS-CoV-2 infection, with higher incidence rates among Black, Hispanic or Latino, and Asian or Pacific Islander individuals. Further research is needed to explore the variations by race/ethnicity and age group.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry

Florence A. Aeschlimann et al.

Summary: This multicenter, international registry aims to describe the clinical and cardiac characteristics of MIS-C associated with COVID-19 in children using CMR. The study found that acute myocarditis is a possible manifestation of MIS-C associated with SARS-CoV-2, with evidence of myocardial necrosis in 18% of the cohort. CMR may be important in identifying patients at risk for cardiac sequelae and more prone to myocardial damage.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2021)

Add to Collection

Article Medicine, Research & Experimental

The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children

Rebecca A. Porritt et al.

Summary: This study characterized the immunopathogenesis of MIS-C using proteomics, RNA sequencing, autoantibody arrays, and BCR repertoire analysis. The findings revealed a strong autoimmune signature with autoantibodies targeting ubiquitously expressed and tissue-specific antigens, as well as a cluster of patients with enhanced neutrophil responses and high levels of anti-Spike IgG and autoantibodies. The research also identified pathogenic pathways that lead to MIS-C, potentially informing treatment strategies.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Medicine, Research & Experimental

HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children

Rebecca A. Porritt et al.

Summary: Our study found a significant expansion of TCR beta variable gene 11-2 (TRBV11-2) in MIS-C patients, with extensive junctional diversity observed in the expanded TRBV11-2 clones. This expansion was correlated with the severity of MIS-C and serum cytokine levels, suggesting a novel mechanism of T cell expansion independent of CDR3. Additionally, in silico modeling indicated a potential interaction between the V beta chain encoded by TRBV11-2 and the superantigen-like motif of SARS-CoV-2 spike glycoprotein, possibly mediating T cell expansion and activation in MIS-C patients.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Pediatrics

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Jonas F. Ludvigsson

ACTA PAEDIATRICA (2020)

Add to Collection

Article Physiology

Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells

Kimberly E. Stelzig et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

Zahra Belhadjer et al.

CIRCULATION (2020)

Add to Collection

Letter Medicine, General & Internal

Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults

Supinda Bunyavanich et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Hyperinflammatory shock in children during COVID-19 pandemic

Shelley Riphagen et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Lucio Verdoni et al.

LANCET (2020)

Add to Collection

Editorial Material Medicine, General & Internal

SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children Different or Shared Etiology and Pathophysiology as Kawasaki Disease?

Brian W. McCrindle et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Immunology

Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study

Ding Shi et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Review Pediatrics

Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review

Joseph Y. Abrams et al.

JOURNAL OF PEDIATRICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Camila Rosat Consiglio et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Conor N. Gruber et al.

CELL (2020)

Add to Collection

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in US Children and Adolescents

Leora R. Feldstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children in New York State

Elizabeth M. Dufort et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors

Roberta Sessa Stilhano et al.

FASEB JOURNAL (2020)

Add to Collection

Article Allergy

Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1

Pui Y. Lee et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS CoV-2

Caroline Diorio et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection

Michael J. Carter et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation

Mary Hongying Cheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Pediatrics

SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome

Marisa Dolhnikoff et al.

LANCET CHILD & ADOLESCENT HEALTH (2020)

Add to Collection

Review Pediatrics

Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment

Jeremy C. McMurray et al.

FRONTIERS IN PEDIATRICS (2020)

Add to Collection

Article Immunology

Considering how biological sex impacts immune responses and COVID-19 outcomes

Eileen P. Scully et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The Y chromosome: a blueprint for men's health?

Akhlaq A. Maan et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2017)

Add to Collection

Review Immunology

Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites

Olivia J. Hall et al.

MUCOSAL IMMUNOLOGY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association

Brian W. McCrindle et al.

CIRCULATION (2017)

Add to Collection

Article Multidisciplinary Sciences

Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination

David Furman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Add to Collection

Article Biochemistry & Molecular Biology

The Y chromosome as a regulatory element shaping Immune cell transcriptomes and susceptibility to autoimmune disease

Laure K. Case et al.

GENOME RESEARCH (2013)

Add to Collection

Review Endocrinology & Metabolism

The complex role of estrogens in inflammation

Rainer H. Straub

ENDOCRINE REVIEWS (2007)

Add to Collection

Article Immunology

Association between a novel human coronavirus and Kawasaki disease

F Esper et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.